Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laodianhuang is a Chinese health and biotechnology company specializing in anti-aging and longevity research, primarily through the development of bee-derived products. The company operates the Lao Dian Huang Institute of Life Sciences in Suzhou and maintains strategic research collaborations with the Institute of Apicultural Research at the Chinese Academy of Agricultural Sciences. Its core product line includes freeze-dried queen bee larva powder and royal jelly tablets, which are produced using advanced vacuum freeze-drying technology to preserve bioactive components like 10-HDA and essential peptides. Marketed for their potential to regulate hormones, improve skin health, and extend healthspan, Laodianhuang's products are positioned at the intersection of traditional health supplements and modern biotechnology. The company's research focuses on longevity-regulating pathways, such as the DAF-16 and IIS pathways, to validate the efficacy of its natural therapeutic offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laodianhuang.